23.01.2025
The pharmaceutical market is characterized by high dynamism. Every year, manufacturers register dozens of new drugs, and pharmaceutical companies actively compete for the attention of doctors and pharmacists.
2 years ago, Promo Test team launched new research “Key Opinion Leaders in Healthcare” in Uzbekistan. Today, the project is rapidly developing and is highly recognized, which testifies to its relevance and demand.
In Kazakhstan and Ukraine, the projects have been successfully functioning for several years already, confirming their importance for the medical community. Data is regularly updated and provided for each country, forming a rating of leading healthcare professionals.
In a highly competitive environment, it is critical to identify key players in the healthcare industry. These experts, known as Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs), play a crucial role in shaping medical recommendations and influencing patient choice. We have previously covered this topic on our website in the article “Leaders of public opinion and influential figures”.
To help pharmaceutical companies better understand key healthcare professionals, a ranking of KOLs / DOLs is generated based on Promo Test’s regular survey of promotional activity.
The study covers:
Respondents were asked who they consider to be the leading healthcare professionals whose opinion is important to them.
The results are presented in the form of a rating that shows the top opinion leaders for each medical specialty.
The project is being implemented in 3 countries:
This allows assessing the influence of regional opinion leaders, providing deeper analysis for pharmaceutical companies.
Opinion leaders, both traditional and digital, are an integral part of the modern pharmaceutical market. Their influence on shaping public opinion, adapting innovations and promoting brands cannot be overemphasized. Effective cooperation with KOLs and DOLs becomes the key to success for pharmaceutical companies.
For up-to-date ratings and additional information, please contact your manager at Proxima Research.
By clicking the “Subscribe” button, you consent to the processing of personal data and the receipt of electronic messages about Proxima Research products and services, and you agree to our Terms of Use. Your data will be processed in accordance with our Privacy Policy. You can unsubscribe at any time.
or